foreign investment
Foreign Investment Series

Foreign Investments Series 1: Handbook on Foreign Direct Investment

August 19, 2025 - By 

Private Equity/Venture Capital Deals: July 2025

August 7, 2025 – By Nakshatra Gujrati

July 2025 kept the private equity investment momentum going with a mix of mega secondary transactions, growth-stage bets, and niche early-stage plays. The highlight was Brookfield and EQT’s potential $3 billion acquisition of Gland Pharma from China’s Fosun Group, marking a significant strategic shift in the healthcare sector. Orix’s $1.28 billion exit from Greenko Energy, paired with a reinvestment of $731 million into AM Green, showcased long-term bullishness in India’s clean energy ecosystem. On the consumer side, ChrysCapital acquired a majority stake in Theobroma for $290 million, signaling private equity’s growing appetite for brand-led FMCG and retail stories.

Pages: 1 2

I'm Nakshatra Gujrati, a final-year law student at National Law University Odisha with a strong focus on private equity, venture capital, and securities regulation. I’ve interned with top-tier firms like Trilegal, Saraf & Partners, and River Law, where I worked hands-on with investment transactions, regulatory advisory, and corporate structuring. As the founder of Track Deal, I track and simplify deal-making trends across the PE/VC landscape. My writing has been published by platforms like SSRN, LiveLaw, and Manupatra, reflecting my passion for bridging law, markets, and innovation. Always exploring the commercial side of law—with a tennis racket in hand when time permits.

Leave a Reply

Your email address will not be published. Required fields are marked *